| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IMGN | ImmunoGen, Inc. | Evp R&D & Medical Affairs | $0 | Feb 12, 2024 | ||
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Director | Aug 15, 2022 |
| Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
|---|